PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process

29 Jan 2026 17:49 CET

Oslo (Norway), 29 January 2026 - PCI Biotech (OSE: PCIB) refers to its latest
announcement of 8 January 2026 regarding the discontinuation of all R&D
operations and the continued exploration of strategic alternatives.

This evaluation has now been concluded. Following careful consideration of the
PCI Biotech group's circumstances, the Board has resolved to initiate a process
to evaluate the opportunity for a structured wind-up.

The liquidity position of the PCI Biotech group remains critical, casting
significant doubt on the group's ability to continue as a going concern. No
assurance can be given for a successful wind-up process.

Further information will be provided when appropriate.

PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo, www.pcibiotech.com

Ronny Skuggedal, CEO
Email: rs@pcibiotech.no
Mobile: +47 9400 5757

Forward-looking statements
This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements.
PCI Biotech disclaims any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act. This stock exchange
announcement was published by Ronny Skuggedal, CEO at PCI Biotech Holding ASA,
on 29 January 2026 at 17:50 CET.

More information:
Access the news on Oslo Bors NewsWeb site